Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Microbiome as a Modifiable and Predictive Factor in Obesity Treatment: Impact of Nutritional Intervention With Probiotics and Prebiotics.

NCT06722443 is registered in ClinicalTrials.gov with Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental as lead sponsor.

NCT NCT06722443
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06722443 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Microbiome as a Modifiable and Predictive Factor in Obesity Treatment: Impact of Nutritional Intervention With Probiotics and Prebiotics.
Lead sponsor
Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
February 1, 2024
Completion date
May 1, 2025
Enrollment
230 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic syndrome, obesity and overweight, obesity, morbid